Cover Image

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

CC BY

Saved in:
Bibliographic Details
Main Authors: Marius, Trøseid, José R., Arribas, Lambert, Assoumou
Format: Book
Language:English
Published: Springer 2023
Subjects:
Bari-SolidAct
placebo-controlled phase 3 trial
Online Access:https://link.springer.com/article/10.1186/s13054-022-04205-8
https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:localhost:PNK-7298
record_format dspace
spelling oai:localhost:PNK-72982023-03-29T08:40:50Z Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial Marius, Trøseid José R., Arribas Lambert, Assoumou Bari-SolidAct placebo-controlled phase 3 trial CC BY Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. 2023-03-29T08:40:50Z 2023-03-29T08:40:50Z 2023 Book https://link.springer.com/article/10.1186/s13054-022-04205-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298 en application/pdf Springer
institution Digital Phenikaa
collection Digital Phenikaa
language English
topic Bari-SolidAct
placebo-controlled phase 3 trial
spellingShingle Bari-SolidAct
placebo-controlled phase 3 trial
Marius, Trøseid
José R., Arribas
Lambert, Assoumou
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
description CC BY
format Book
author Marius, Trøseid
José R., Arribas
Lambert, Assoumou
author_facet Marius, Trøseid
José R., Arribas
Lambert, Assoumou
author_sort Marius, Trøseid
title Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
title_short Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
title_full Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
title_fullStr Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
title_full_unstemmed Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
title_sort efficacy and safety of baricitinib in hospitalized adults with severe or critical covid-19 (bari-solidact): a randomised, double-blind, placebo-controlled phase 3 trial
publisher Springer
publishDate 2023
url https://link.springer.com/article/10.1186/s13054-022-04205-8
https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298
_version_ 1761731322107133952
score 8.881002

Similar Items